Primary carcinoma of the vagina

Journal of B.U.ON.

Volumn 15, Issue 2, 2010, Pages 241-247

  Lilic, Vekoslav ^a   Lilic, G ^a   Filipovic, S ^a   Visnjic, M ^a   Zivadinovic, R ^a  

^a Clinical Centre Nis   (Serbia)

Author keywords

Carcinoma; Diagnosis; Prognosis; Therapy; Vagina

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

CANCER RISK; CANCER STAGING; HUMAN; HYSTERECTOMY; METASTASIS; PAPANICOLAOU TEST; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROGNOSIS; RADIATION DOSE; REVIEW; VAGINA CARCINOMA; VAGINAL INTRAEPITHELIAL NEOPLASIA; WART VIRUS;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; VAGINAL NEOPLASMS;

EID: 77954409428     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Beller U, Benedet JL, Creasman TW et al. Carcinoma of the vagina. 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynecol Obstet 2006; 95 (Suppl 1): S29-S42.
2. Fu Y. Benign and Malignant Epithelial Neoplasms of the vagina. In: Fu Y (Ed): Pathology of the Uterine Cervix, Vagina and Vulva. Philadelphia: Saunders, 2002, pp 232-268.
3. Murad TM, Durant JR, Madox WA, Dowling EA. The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancer. Cancer 1975; 35: 787-784.
4. Brinton LA, Nasca PC, Millin K et al. Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 1990; 38: 49-54. (Pubitemid 20206225)
5. Daling JR, Sherman KJ, Hislop TG et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135: 180-189.
6. Hildesheim A, Han CL, Brinton LA et al. Sexually transmitted agents and risk of carcinoma of the vagina. Int J Gynecol Cancer 1997; 7: 251-255. (Pubitemid 27458967)
7. Daling JR, Madeleine MM, Schwartz SM et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84: 263-270.
8. Arbeit JM, Howley PM, Nanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 1996; 93: 2390-2395.
9. Diakomanolis E, Stefanidis K, Rodolakis A et al. Vaginal intraepithelial neoplasia (VAIN): Report of 102 cases. Eur J Gynecol Oncol 2002; 23: 457-459 (Review). (Pubitemid 35364680)
10. Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 1994; 139: 64-76. (Pubitemid 24048067)
11. Goodman A. Primary vaginal cancer. Surg Oncol Clin N Am 1998; 7: 347-361.
12. Lee YC, Holkomb K, Buhl A, Abulafia O. Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman. Gynecol Oncol 2000; 78: 380-382.
13. Newman W, Cramer JD. The multicentric origin of carcinomas of the female anogenital tract. Surg Gynecol Obstet 1989; 108: 273-281.
14. Stock RG, Chen AS, Seski J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 1995; 56: 45-52.
15. Herman J, Homesely HD, Dignan MB. Is hysterectomy a risk factor for vaginal cancer? JAMA 1986; 256: 601-603.
16. Bell J, Sevin BU, Averette H, Nadji M. Vaginal cancer after hysterectomy for benign disease: value of cytologic screening. Obstet Gynecol 1994; 64: 699-702.
17. Pride GL, Buchler DA. Carcinoma of vagina 10 or more years following pelvic irradiation therapy. Am J Obstet Gynecol 1977; 127: 513-517. (Pubitemid 8060326)
18. Bailer U, Maisoneuve P, Benedet JL. Carcinoma of the vagina. Int J Gynecol Obstet 2003; 83 (Suppl 1): 27-39.
19. Lee YC, Holkomb H, Buhal A, Holden J, Abulafia O. Rapid progression of the primary vaginal squamous cell carcinoma in women. Gynecol Oncol 2000; 78: 380-382.
20. Frich HC, Jacox HW, Taylor HC. Primary carcinoma of the vagina. Am J Obstet Gynecol 1968; 101; 695-700.
21. Foroudi F, Bull CA, Gepski V. Primary invasive cancer of the vagina: outcome and complications of therapy. Australs Radiol 1999; 43: 472-475. (Pubitemid 29526100)
22. Rome RM, England PG. Management of vaginal intraepithelial neoplasia: A series of 132 cases with long-term follow-up. Int J Gynecol Cancer 2006; 16: 884-891.
23. Hellman K, Silfverward C, Nilsson B, Hellstrom AC, Frankendal B, Petersson F. Primary carcinoma of the vagina: factors influencing the age at diagnosis. Int J Gynecol Cancer 2004; 13: 491-501.
24. Torizukua T, Kanno T, Futatsubashi M et al. Imaging of gynecologic tumors: comparison of (11) C-choline PET with (18) F-FDGPET. J Nucl Med 2003; 44: 1051-1056.
25. Whelton J, Kottmeier L. Primary carcinoma of the vagina. Acta Obstet Gynecol Scand 1982; 41: 22-40.
26. Kosary CL. FIGO stage, histology, histological grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of endometrium, cervix, ovary, vulva and vagina. Semin Surg Oncol 1994; 10: 31-46.
27. Al-Kurdi M, Monaghan JM. Thirty-two years experience in the management of primary tumors of the vagina. Br J Obstet Gynecol 1981; 88: 1145-1150. (Pubitemid 12228265)
28. Lemien A, Forss M, Lehtovirta P. Therapeutic and prognostic considerations in primary carcinoma of the vagina. Acta Obstet Gynecol Scand 1995; 74: 379-383.
29. Compagnutta E, Parin A, De Piero G, Giorda G, Gallo A, Scarabelli C. Treatment of vaginal intraepithelial neoplasia (VAIN) with carbon dioxide laser. Clin Exp Obstet Gynecol 1999; 26: 127-130. (Pubitemid 29322133)
30. Wertheim E. Abdominal total extirpation der vagina. Gznak 1900; 24: 1393-1396.
31. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma: a one-stage abdomino-perineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948; 1: 177-183.
32. Tjalma WA, Monaghan JM, de Baros Lopes A, Naik R, Nordin AJ, Weyler JJ. The role of surgery in invasive squamous carcinoma of the vagina. Gynecol Oncol 2001 ; 81: 360-365.
33. Urbanski K, Kojs Z, Reinfuss M, Fabisiak W. Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 1996; 60: 16-21. (Pubitemid 26028450)
34. Ball HG, Berman ML. Management of primary vaginal carcinoma. Gynecol Oncol 1982; 14: 154-163.
35. Kucera H, Vavra N. Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 1991 ; 40: 12-16.
36. Petterson F. Annual report on the results of treatment in gynecologic cancer. FIGO 1987-1993. Stockholm: Radiumhemmet 1999; 6: 22-29.
37. Kucera H, Mock U, Knocke TH, Kucera E, Potter E. Radiotherapy alone for invasive vaginal cancer outcome with intracavitary high-dose rate brachytherapy. Acta Obstet Gynecol Scand 2001; 80: 355-360.
38. Mock U, Kucera H, Fellner C. High dose rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys 2003; 56: 950-957. (Pubitemid 36794025)
39. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 2005; 62: 138-147. (Pubitemid 40591935)
40. Grigsby PW. Vaginal cancer. Curr Treat Options Oncol 2002; 3: 125-130.
41. Darlumple JL, Russell AH, Lee SW et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 2004; 14: 110-117. (Pubitemid 38280632)
42. Grigspi PW. Cervical cancer: combined modality therapy. Cancer J 2001; (Suppl 1): 47-50.
43. Concurrent chemoradiation for cervical cancer. Natl Cancer Inst Clinical Announcement, 1999.
44. Thigpen JT, Blessing JA, Homesley HD, Berek JS, Creasman WT. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: A Gynecologic Oncology Group Study. Gynecol Oncol 1986; 23: 101-104. (Pubitemid 16133443)
45. Zanetta G, Lissoni A, Landoni F et al. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 1997; 64: 431-435. (Pubitemid 27120431)